Journals
.jpg)
.jpg)
Current IACM-Bulletins
The IACM-Bulletin is a FREE bi-weekly e-mail newsletter, covering news topics on all aspects of Cannabis as medicine. To receive IACM-Bulletin per e-mail, please subscribe online.
[IACM Homepage] [IACM-Bulletin Year 2023] [2022] [2021] [2020] [2019] [2017] [2016] [2015] [2014] [2013] [2012] [2011] [2010] [2009] [2008] [2007] [2006] [2005] [2004] [2003] [2002] [2001] [2000]
- IACM-Bulletin of 11 November 2018
- USA: Utah and Missouri legalise the medical use of cannabis, Michigan approves recreational use
- Science/Human: Cannabis may be helpful in the treatment of children with autism in an open study
- Mexico: Mexico Supreme Court calls ban on recreational cannabis use unconstitutional
- UK: Cannabis may now be used for certain medical conditions
- IACM-Bulletin of 14 October 2018
- UK: Cannabis will be made available for medical use in November 2018
- UNO: In March 2019 countries will vote on recommendations by the WHO on the classification of cannabis
- Science/Human: Cannabis use is associated with significant reduction in occurrence of diabetes
- Science/Human: Cannabis is effective in Tourette syndrome according to a survey
- Science/Human: Cannabidiol may be useful in the treatment of cancer according to an observational study
- IACM-Bulletin of 30 September 2018
- South Africa: Constitutional Court allows private use of cannabis
- Science/Human: Drug addicts have higher retention to opioid replacement treatment if they use cannabis
- Science/Human: Cannabis extract with high CBD and low THC content effective in childhood epilepsy
- Science/Human: Cannabis improves pain in patients with failed back surgery syndrome
- Science/Human: No difference on reduced appetite between THC, megestrol and mirtazapine
- IACM-Bulletin of 19 August 2018
- Science/Human: Medical cannabis laws in the USA are associated with improved workplace safety
- Science/Human: The risk of dependence formation among heavy cannabis users in the USA declined in the past 15 years
- Science/Human: Patients with insomnia experience improved sleep by the use of cannabis
- Science/Human: Large study with CBD in patients with epilepsy demonstrates good long-term safety of the medication
- IACM-Bulletin of 05 August 2018
- IACM: The journal “Cannabis and Cannabinoid Research” will be transitioning to a hybrid publication
- UK: Government wants to allow limited access to the medical use of cannabis
- Science/Human: Nabilone improves agitation and other behavioural symptoms in patients with Alzheimer’s disease
- Georgia: The Constitutional Court rules that people can no longer be punished for using cannabis
- IACM-Bulletin of 22 July 2018
- IACM: Nomination of IACM Ambassadors
- Science/Human: Legalization of cannabis for medical use in the US is associated with reduced opioid prescriptions
- Science/Human: Cannabis use is associated with decreased mortality in hospital after a heart attack
- Science/Human: CBD reduces seizures in several further childhood-onset epilepsy forms according to an open-label study
- IACM-Bulletin of 08 July 2018
- Switzerland: The government intends to ease access to the medical use of cannabis
- USA: Health authority approves CBD-rich cannabis extract for the treatment of epilepsy
- Luxembourg: The country will legalise the medical use of cannabis
- USA: Oklahoma becomes the 30th state to legalise the medical use of cannabis
- Science/Human: Cannabis reduces pain in multiple sclerosis
- Science/Human: Cannabis tea effective in the treatment of chronic pain
- IACM-Bulletin of 24 June 2018
- IACM: Medical Cannabis and Cannabinoids, a new partner journal of the IACM
- Canada: The country legalizes cannabis
- Portugal: Parliament approves bill for the medical use of cannabis-based medicines
- Science/Human: External use of CBD improves symptoms of severe skin disease in 3 children
- UK: Government signals changes on medicinal cannabis use
- IACM-Bulletin of 29 April 2018
- Science/Human: Cannabis use reduces mortality in patients with burns
- Science/Human: A cannabis extract with THC and CBD reduced seizures in epilepsy in an open study
- Science/Human: Acute use of cannabis may reduce anxiety and depression according to large study
- Science/Human: CBD may be used against anxiety and depression without altering normal sleep
- IACM-Bulletin of 04 March 2018
- IACM: The Ambassadorship Program is open for applications
- Science/Human: Heavy cannabis use in patients with HIV is associated with improved immune function
- Science/Human: Cannabis is effective in alleviating symptoms of cancer patients
- Science/Human: Cannabis may have a beneficial effect on patients with fibromyalgia
- Science/Human: Cannabis enhances the pain reducing effects of the opioid oxycodone according to experimental study
[IACM Homepage] [IACM-Bulletin Year 2023] [2022] [2021] [2020] [2019] [2017] [2016] [2015] [2014] [2013] [2012] [2011] [2010] [2009] [2008] [2007] [2006] [2005] [2004] [2003] [2002] [2001] [2000]
Online Events 2020
Please find all information of IACM Online Events including free videos of the webinars here.
Conference 2022
The 12th IACM Conference on Cannabinoids in Medicine will be we be held on 20 and 21 October 2022 together with the Swiss SSCM in Basel/Switzerland.
Members only
Regular members can sign up for the new member area of the IACM to access exclusive content.
You need to become a regular member of the IACM to access the new member area.
IACM on Twitter
Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.